Methods

Study population
This was a longitudinal survey in KZN. This research was an ancillary study to a larger cohort study investigating the health and psychosocial needs of children. The parent study enrolled 1 787 children aged 4 -6 years identified in a door-to-door survey in the Valley of a Thousand Hills. The current study was conducted when these children were undergoing follow-up assessments at ages of between 6 and 8 years. A total of 184 consecutive children over a 4-month period were invited to join this study.
Diagnostic testing
Haemoglobin (Hb) determination by HaemoCue (Angelholm, Sweden) was conducted by a clinician. Anaemia was defined using Hb levels. The World Health Organization (WHO)-recommended cut-offs were used to classify anaemia severity. Children aged up to 59 months had an Hb cut-off of 11.0 g/dL, and 11.5 g/dL was applied for children 5 -11 years old. Children aged up to 59 months had anaemia categorised as mild for Hb levels 10.0 -10.9 g/dL, moderate 7.0 -9.9 g/dL and severe <7.0 g/dL, while for children 5 -11 years of age anaemia was classified as mild with Hb levels 11.0 -11.4 g/dL, moderate 8.0 -10.9 g/dL and severe <8.0 g/dL [4] Stool and urine samples were collected and sent for microscopy at a local academic hospital. All caregivers and children were offered voluntary HIV counselling and testing.
Analysis of time and treatment effects on anaemia
This exploratory analysis utilised Hb measurements from two time-points: the baseline at enrolment into the parent study; and at follow-up, which occurred at least 18 months later. The two Hb measurements were used to determine the Hb trend over time. We assessed within-group differences for participants who had anaemia at these two time-points. Individual analyses were carried out for all the study participants. Parasitic infections were referred to as severe if the child had the presence of symptoms such as diarrhoea, abdominal pain and blood in stool. Asymptomatic cases were documented as mild.
Statistical analyses
SPSS version 22 software (IBM, USA) was used for data entry and analysis. The distribution of anaemia, and effect of infection and treatment were assessed using descriptive statistics and graphical plots. Characteristics of the children in each defined group were compared using Student's t-test and χ 2 tests as appropriate.
Ethical review
This research study was approved by the University of KZN Biomedical Research Ethics Committee. Informed consent was obtained from the children's caregivers before enrolment. All children with Hb <10 g/dL were referred for clinical intervention.
Results
Population characteristics
Hb levels at both baseline and follow-up were available for 181 of 184 (98.4%) participants. At baseline, the children were aged 47 -77 months (standard deviation (SD) 0.58) and at follow-up 72 -102 months (SD 0.55). The study group comprised more males (109/184 (59.2%)) than females. All children were asymptomatic for anaemia.
Anaemia profile
At baseline, the prevalence of anaemia was 103/181 (56.9%). Among the anaemic, 2/103 (1.9%) children had severe anaemia, 62/103 (60.2%) moderate and 39/103 (37.9%) mild. A significant declining trend was seen at follow-up, with an anaemia prevalence of 76/181 (42%), with 1/76 (1.3%) severe anaemia, 45/76 (59.2%) moderate and 30/76 (39.5%) mild (p=0.002). Generally, there was a trend towards a higher mean Hb with time for all children ( Table 1 ). The mean (SD) Hb at follow-up (11.7 (1.19) g/dL) was higher than at baseline (11.2 (1.14 g/dL) (95% confidence interval (CI) -0.71 --0.23)). Of the non-anaemic children at baseline, 21/78 (26.9%) were anaemic at follow-up. Among the anaemic children at baseline, 43/103 (41.8%) were still anaemic at follow-up. The two children who had severe anaemia at baseline did not have anaemia at follow-up. Of the 62 with moderate anaemia at baseline, 27/62 (43.6%) persisted with anaemia. Of the children with anaemia at baseline, 14/103 (13.6%) were found to have lower Hb levels at follow-up, with one child who initially had Hb 11.1 g/dL present with severe anaemia (Hb 6.6 g/dL) at follow-up.
At baseline, 27/103 (26.2%) children with Hb <10 g/dL were referred for clinical inter vention at their local clinic. At follow-up, 18/27 (66.7%) children were still anaemic, although 23/27 (85.2%) had improved Hb levels. Of the children with persistent anaemia, 7/27 (25.9%) continued to have Hb levels <10 g/dL despite referral for clinical management.
Clinical factors
HIV infection
A total of 168/181 (92.8%) children were tested for HIV at baseline and 3/168 (1.8%) were HIV-positive. Two of these children had mild anaemia at baseline. A non-significant increased uptake for HIV testing was seen at follow-up (179/181 (98.9%)), with 5/179 (2.8%) children testing positive for HIV infection. HIV-positive children had a trend towards lower Hb (11.22 g/dL, SD 0.81) than HIV-negative children (12. 19 g/dL, SD 1.19) children (95% CI -4.27 --1.32). At followup, all five HIV-infected children were anaemic with an Hb range of 8.0 -11.4 g/dL: 2 mild, 2 moderate and 1 severe anaemia.
Parasitic infection
A total of 52/181 (28.7%) children had a history of expelled worms prior to the assessment. Of these, 49 (94.2%) had mild asymptomatic infections and 2/52 (3.8%) had severe symptomatic infections. The age of the children at the time of expelling the worms ranged from 7 to 60 months, with a mean (SD) age of 31 (13.1) months. A total of 107/181 (59.1%) participants had received deworming treatments within the past 12 months. Of these, 37/107 (34.6%) were anaemic at follow-up. A total of 178/181 (98.3%) urine and stool samples were tested for parasitic infection in the second survey. Microscopy was positive for parasites in 43/178 (24.2%) children, although only 31/178 (17.4%) had pathological infection. Pathogens identified were Ascaris lumbricoides (10/31 (32.3%)), Giardia lamblia (18/31 (54.8%)), Blastocystis hominis (1/31 (3.2%)), Enterobius vermicularis (2/31 (6.5%)), Trichuris trichiura (1/31 (3.2%)), Entamoeba coli (8/31 (25.8%)) and Schistosoma haematobium (3/31 (9.4%)). Of the children with parasitic infection, 14/31 (45.2%) had anaemia compared with 31/147 (21.1%) without helminth infection. Anaemia trends for individual pathogens were Ascaris spp. (3/10 (30.0%)), S. haematobium (1/3 (33.3%)), G. lamblia (9/18 (50.0%)), E. coli 4/8 (50.0%) and B. hominis 0/1. The contribution of parasite infestation to anaemia was statistically significant (p=0.03). Deworming had a significant effect on anaemia at followup (p=0.01).
Exploratory analysis of the trend in anaemia and haemoglobin over time
There was no statistical difference in anaemia between those who had been referred for treatment and those who had not ( Table 2 ). The
Table 1. Change in haemoglobin levels according to anaemia presence at baseline n Mean change in Hb g/dL between followup and baseline, mean (95% CI) p-value
Anaemic at baseline 103 0.47 (0.18 -0.75) 0.002
Non-anaemic at baseline 78 0.40 (0.12 -0.69) 0.006
All participants 181 0.47 (0.23 -0.72) 0.000 researchers did not explore the differences between HIV-infected children because of the small sample size. Children who received deworming treatment had a trend towards higher mean increase in Hb compared with children who did not receive deworming treatment. The mean difference between baseline and follow-up Hb levels for children who had been referred for treatment was 2.4 g/dL (95% CI 1.86 -2.88) while the mean difference in Hb levels for those who had not received treatment was 0.7 g/ dL (0.39 -1.07). This difference was clinically significant (p<0.005).
Discussion
The prevalence of anaemia in this study population was high: 57.2% at baseline and 42.2% at follow-up. The researchers suggest that the high anaemia burden among this study population could be attributed to high levels of poverty, food insecurity and infectious diseases in the community. Anaemia persisted in 41.8% of children who were found to be anaemic at baseline. Moreover, over a quarter of initially non-anaemic children (26.9%) developed anaemia (based on WHO criteria) over the 2-year interval. Concern regarding this high anaemia burden in school-aged children remains owing to the commonly asymptomatic nature of anaemia and the inadequate treatment rates for those children who do seek healthcare. This study found evidence to suggest that deworming has a beneficial effect on anaemia prevention, while clinical interventions to treat anaemia in earlier childhood may not prevent anaemia in later childhood. It is thought that the anaemia was related to iron deficiency and exacerbated by infections. This high prevalence of anaemia in schoolaged children highlights the need to consider additional strategies for anaemia control for this population. The WHO, which compiled a systematic review of country-level data from 1993 to 2005, estimated a global anaemia prevalence of 25.4% (305 million children) among school-age children. [5] Very few data were available on school-aged children in most African countries, including SA. For this global database to achieve maximum potential, investigations need to be carried out and additional information gathered on Hb levels in schoolaged children. The prevalence findings from this study were in stark contrast to the recent 2013 SANHANES-1 [6] report, which described a very low anaemia prevalence of 10.5% in children up to 14 years old. However, the findings from the present study are more comparable with earlier national surveys [7, 8] and local studies, [9, 10] which reported anaemia prevalence ranging from 16.5 to 33%. The ages of children assessed, methods of determining Hb concentration and anaemia Hb-level cut-offs varied from those used in this current study. Hence, the outcomes on anaemia prevalence need to be compared with caution.
Although studies implementing micronutrient supplementation in early childhood as a primary prevention strategy have been encouraging, the findings from this study suggest that this strategy may not prevent anaemia in later childhood. The variety of treatments received and duration of treatment make comparisons challenging. Several studies have reported difficulties in finding adequate evidence to detect significant effects and the few trials available provided limited evidence of benefit. [11, 12] Anaemia burden was high among children with HIV and parasitic infections. This identifies these groups for targeted interventions. Strategies to increase uptake of HIV testing by caregivers need to be endorsed. The uptake for HIV testing (98.9%) was higher than that reported by another local study (41.0%). [13] Public health campaigns are needed to encourage HIV testing for children. Parents who miss the opportunity during pregnancy may be offered routine systematic testing of their children at later ages. Parasitic infestation was found in 17.7% children and contributed significantly to anaemia presence (p=0.03). The re-infection rate following treatment was 24.3%. The pathogens identified were comparable with other local studies, which reported variable parasitic infection of T. trichiura (53.9 -86.2%), A. lumbricoides (19.4 -85%), hookworm (20 -83.2%) and S. haematobium (24.5%). [14] [15] [16] The KZN helminth control programme is school based. By this age, a large proportion of the children are already affected by anaemia, hence the guidelines may require refinement in order to optimise benefits.
Recommendations
Global complementary efforts are necessary to promote good nutritional status and reduce common infections in children. Chronic anaemia, including iron depletion and anaemia of inflammation, needs to be addressed. The appropriate execution of the Integrated Management of Childhood Illness programme is expected to result in better case identification and management for children with anaemia. The Expanded Programme on Immunization (EPI) has also achieved good national coverage and may be an effective vehicle for the provision of interventions for controlling anaemia and infections in children up to school age. Interventions providing dietary support need to be complemented with attempts to increase screening and treatment for anaemia, helminth infection and HIV in children at risk. Long-term interventions and policies that target individual, community and national levels are needed, recognising the effect of different cultural practices and financial restrictions.
